About: CapOpus   Goto Sponge  NotDistinct  Permalink

An Entity of Type : yago:WikicatOrganizationsBasedInDenmark, within Data Space : wasabi.inria.fr associated with source document(s)

CapOpus is the name of a randomized controlled trial (RCT) running in Denmark at Psychiatric Center Bispebjerg (part of Region Hovedstadens Psykiatri) and physically located at Bispebjerg Hospital in Copenhagen. It is an intervention aimed at reducing cannabis consumption in young persons with comorbid severe mental illness such as schizophrenia or schizotypal personality disorder, and cannabis dependency. It is run by psychiatrist Merete Nordentoft. The presence of mental illness and cannabis dependency, abuse, or harmful use is established using the SCAN interview's chapters 11 and 12.

AttributesValues
type
label
  • CapOpus
comment
  • CapOpus is the name of a randomized controlled trial (RCT) running in Denmark at Psychiatric Center Bispebjerg (part of Region Hovedstadens Psykiatri) and physically located at Bispebjerg Hospital in Copenhagen. It is an intervention aimed at reducing cannabis consumption in young persons with comorbid severe mental illness such as schizophrenia or schizotypal personality disorder, and cannabis dependency. It is run by psychiatrist Merete Nordentoft. The presence of mental illness and cannabis dependency, abuse, or harmful use is established using the SCAN interview's chapters 11 and 12.
sameAs
topic
described by
subject
dbo:wikiPageID
Wikipage revision ID
dbo:wikiPageWikiLink
Link from a Wikipage to an external page
is primary topic of
wasDerivedFrom
http://purl.org/li...ics/gold/hypernym
dbo:abstract
  • CapOpus is the name of a randomized controlled trial (RCT) running in Denmark at Psychiatric Center Bispebjerg (part of Region Hovedstadens Psykiatri) and physically located at Bispebjerg Hospital in Copenhagen. It is an intervention aimed at reducing cannabis consumption in young persons with comorbid severe mental illness such as schizophrenia or schizotypal personality disorder, and cannabis dependency. It is run by psychiatrist Merete Nordentoft. The aim of the RCT is to compare an approach using motivational interviewing, cognitive behaviour therapy, and the stages of change model compared with standard treatment. Among the trial's funders are the Lundbeck foundation, the Municipality of Copenhagen, and Sygekassernes Helsefond. The primary outcome of the trial is reduction in number of days using cannabis, as measured by the instrument. As secondary outcomes, the trial measures level of psychopathology in terms of positive and negative symptoms with the PANSS instrument; cognitive function using a set of validated tests; and quality of life and related life-areas measured with the Manchester Short Assessment of Quality of Life instrument and the World Health Organization's Disability Assessment Schedule. The presence of mental illness and cannabis dependency, abuse, or harmful use is established using the SCAN interview's chapters 11 and 12. The trial is, along with the English MIDAS Trial, among the only trials aimed at this particular group of comorbid substance abusers with schizophrenia.
dbp:date
dbp:url
dbo:wikiPageLength
dbp:wikiPageUsesTemplate
is sameAs of
is topic of
is dbo:wikiPageWikiLink of
is Wikipage redirect of
is topic of
is http://vocab.deri.ie/void#inDataset of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software